Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis of frontal fibrosing alopecia is crucial to prevent permanent hair loss.

Frontal fibrosing alopecia in postmenopausal women can be managed with early treatment using corticosteroids to stop hair loss.

Familial frontal fibrosing alopecia affects premenopausal women too, and early diagnosis is important, but no proven medication exists yet.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Sunscreen use is linked to frontal fibrosing alopecia, especially in males.

A genetic marker linked to a type of hair loss was found in most patients studied.

FAI is a reliable marker for identifying and monitoring hyperandrogenism in obese adolescent females with PCOS.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Hair transplantation may not work for Frontal Fibrosing Alopecia as transplanted hair was lost when the disease came back.

Certain genetic factors may contribute to frontal fibrosing alopecia in Brazil.

Frontal Fibrosing Alopecia is a type of hair loss that mainly affects postmenopausal women, has unclear causes, and lacks evidence-based treatments.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

Frontal fibrosing alopecia is linked to four genetic areas, especially the HLA-B*07:02 allele.

Trichoscopy is useful for diagnosing Frontal Fibrosing Alopecia.

Frontal fibrosing alopecia in families shows similar signs to individual cases and may have a genetic link.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Using ultrasound to guide temple filler injections improves safety and accuracy.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

The document concludes that doctors should check for frontal fibrosing alopecia in patients with acquired hyperpigmentation and that early treatment is important.

Frontal Fibrosing Alopecia mainly affects postmenopausal Mexican women, requiring early detection to prevent permanent hair loss.

A patient had both chronic cutaneous lupus erythematosus and frontal fibrosing alopecia.

Frontal fibrosing alopecia causes hair loss along the frontal hairline, mainly in postmenopausal women, and needs better treatments.

Early diagnosis and a multidisciplinary approach are crucial for managing Frontal Fibrosing Alopecia.

FFA in men, often mistaken for other hair loss types, may be more common than thought and needs larger studies for confirmation.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

Frontal fibrosing alopecia and vitiligo might be linked by similar immune issues.

Frontal Fibrosing Alopecia mainly affects postmenopausal women and is linked to thyroid disease, hyperlipidemia, and anemia.

Finasteride was more effective than hydroxychloroquine in treating frontal fibrosing alopecia.

Frontal fibrosing alopecia mainly affects postmenopausal women and may be linked to thyroid hormones.